Mark Dowling is currently the Head of External Innovation in Immunology at Sanofi Genzyme. Previously, they served in various leadership roles at Kaleido Biosciences and the Novartis Institutes for BioMedical Research, where they managed teams in translational sciences and respiratory pharmacology. Mark contributed to significant advancements in receptor pharmacology and assay development, including the establishment of innovative methodologies for drug discovery. They hold a Ph.D. in GPCR Pharmacology from the University of Leicester.
This person is not in the org chart
This person is not in any teams
This person is not in any offices